Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

The Role of Personality in Treatment-Related Outcome Preferences Among Pharmacy Students.

Law EH, Jiang R, Kaczynski A, Mühlbacher A, Pickard AS.

Am J Pharm Educ. 2019 Sep;83(7):6891. doi: 10.5688/ajpe6891.

2.

U.K. utility weights for the EORTC QLU-C10D.

Norman R, Mercieca-Bebber R, Rowen D, Brazier JE, Cella D, Pickard AS, Street DJ, Viney R, Revicki D, King MT; European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group and the MAUCa Consortium.

Health Econ. 2019 Dec;28(12):1385-1401. doi: 10.1002/hec.3950. Epub 2019 Sep 3.

PMID:
31482619
3.

Design of the patient navigator to Reduce Readmissions (PArTNER) study: A pragmatic clinical effectiveness trial.

Prieto-Centurion V, Basu S, Bracken N, Calhoun E, Dickens C, DiDomenico RJ, Gallardo R, Gordeuk V, Gutierrez-Kapheim M, Hsu LL, Illendula S, Joo M, Kazmi U, Mutso A, Pickard AS, Pittendrigh B, Sullivan JL, Williams M, Krishnan JA.

Contemp Clin Trials Commun. 2019 Jul 19;15:100420. doi: 10.1016/j.conctc.2019.100420. eCollection 2019 Sep.

4.

United States Valuation of EQ-5D-5L Health States Using an International Protocol.

Pickard AS, Law EH, Jiang R, Pullenayegum E, Shaw JW, Xie F, Oppe M, Boye KS, Chapman RH, Gong CL, Balch A, Busschbach JJV.

Value Health. 2019 Aug;22(8):931-941. doi: 10.1016/j.jval.2019.02.009. Epub 2019 May 25.

5.

Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission.

Zueger PM, Holmes HM, Calip GS, Qato DM, Pickard AS, Lee TA.

J Gen Intern Med. 2019 Oct;34(10):2029-2037. doi: 10.1007/s11606-019-05152-x. Epub 2019 Jul 25.

PMID:
31346909
6.

A comparison of self-rated health using EQ-5D VAS in the United States in 2002 and 2017.

Cha AS, Law EH, Shaw JW, Pickard AS.

Qual Life Res. 2019 Nov;28(11):3065-3069. doi: 10.1007/s11136-019-02249-y. Epub 2019 Jul 18.

PMID:
31321671
7.

The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30.

McTaggart-Cowan H, King MT, Norman R, Costa DSJ, Pickard AS, Regier DA, Viney R, Peacock SJ.

MDM Policy Pract. 2019 Apr 13;4(1):2381468319842532. doi: 10.1177/2381468319842532. eCollection 2019 Jan-Jun.

8.

Exploring the Internal Structure of the EQ-5D Using Non-Preference-Based Methods.

Feng YS, Jiang R, Kohlmann T, Pickard AS.

Value Health. 2019 May;22(5):527-536. doi: 10.1016/j.jval.2019.02.006.

9.

Latent Class Models Reveal Poor Agreement between Discrete-Choice and Time Tradeoff Preferences.

Pullenayegum EM, Pickard AS, Xie F.

Med Decis Making. 2019 May;39(4):421-436. doi: 10.1177/0272989X19841592. Epub 2019 Apr 13.

PMID:
30982403
10.

Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.

Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-Séverac H, Crawford B, Cruz L, Karnon J, Lloyd A, Paisley S, Pickard AS.

Value Health. 2019 Mar;22(3):267-275. doi: 10.1016/j.jval.2019.01.004. Review.

11.

The EQ-5D and the EuroQol Group.

Lloyd A, Pickard AS.

Value Health. 2019 Jan;22(1):21-22. doi: 10.1016/j.jval.2018.12.002. No abstract available.

12.

Valuation of the EQ-5D-5L in Taiwan.

Lin HW, Li CI, Lin FJ, Chang JY, Gau CS, Luo N, Pickard AS, Ramos Goñi JM, Tang CH, Hsu CN.

PLoS One. 2018 Dec 26;13(12):e0209344. doi: 10.1371/journal.pone.0209344. eCollection 2018.

13.

Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy.

Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R.

Pediatr Pulmonol. 2019 Feb;54(2):179-185. doi: 10.1002/ppul.24203. Epub 2018 Dec 12.

14.

Q-TWiST Analysis to Assess Benefit-Risk of Pembrolizumab in Patients with PD-L1-Positive Advanced or Metastatic Non-small Cell Lung Cancer.

Huang M, Pietanza MC, Samkari A, Pellissier J, Burke T, Chandwani S, Kong F, Pickard AS.

Pharmacoeconomics. 2019 Jan;37(1):105-116. doi: 10.1007/s40273-018-0752-0.

15.

Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.

Law EH, Pickard AS, Xie F, Walton SM, Lee TA, Schwartz A.

Med Decis Making. 2018 Nov;38(8):968-982. doi: 10.1177/0272989X18802797.

PMID:
30403577
16.

Use of Nonpalliative Medications Following Burdensome Health Care Transitions in Hospice Patients: A Matched Cohort Analysis.

Zueger PM, Holmes HM, Qato DM, Pickard AS, Calip GS, Lee TA.

Med Care. 2019 Jan;57(1):13-20. doi: 10.1097/MLR.0000000000001008.

PMID:
30363022
17.

Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice.

Zueger PM, Holmes HM, Calip GS, Qato DM, Pickard AS, Lee TA.

J Am Geriatr Soc. 2018 May;66(5):937-944. doi: 10.1111/jgs.15328. Epub 2018 Mar 6.

PMID:
29509282
18.

Predicting Acute Exacerbations in Chronic Obstructive Pulmonary Disease.

Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA.

J Manag Care Spec Pharm. 2018 Mar;24(3):265-279. doi: 10.18553/jmcp.2018.24.3.265.

19.

3L, 5L, What the L? A NICE Conundrum.

Devlin N, Brazier J, Pickard AS, Stolk E.

Pharmacoeconomics. 2018 Jun;36(6):637-640. doi: 10.1007/s40273-018-0622-9. No abstract available. Erratum in: Pharmacoeconomics. 2018 May 10;:.

20.

Comparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers.

Schumock GT, Pickard AS.

J Comp Eff Res. 2018 Feb;7(2):177-180. doi: 10.2217/cer-2017-0057. Epub 2018 Feb 21.

21.

Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation.

Devine EB, Perfetto E, Pickard AS, Schumock GT, Segal JB, Cannon E, Gagnon JP, Brixner DI, Garrison LP, Murray MD.

J Comp Eff Res. 2018 Feb;7(2):167-175. doi: 10.2217/cer-2017-0059. Epub 2018 Feb 21.

22.

EQ-5D-Y for the assessment of health-related quality of life among Taiwanese youth with mild-to-moderate chronic kidney disease.

Hsu CN, Lin HW, Pickard AS, Tain YL.

Int J Qual Health Care. 2018 May 1;30(4):298-305. doi: 10.1093/intqhc/mzy011.

PMID:
29447362
23.

Lifestyle-related attitudes: do they explain self-rated health and life-satisfaction?

Pickard AS, Jalundhwala YJ, Bewsher H, Sharp LK, Walton SM, Schumock GT, Caskey RN.

Qual Life Res. 2018 May;27(5):1227-1235. doi: 10.1007/s11136-017-1774-3. Epub 2018 Jan 4.

PMID:
29302851
24.

Patient Experience-based Value Sets: Are They Stable?

Pickard AS, Hung YT, Lin FJ, Lee TA.

Med Care. 2017 Nov;55(11):979-984. doi: 10.1097/MLR.0000000000000802.

PMID:
29028757
25.

Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β2-Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid.

Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA.

Ann Pharmacother. 2017 Nov;51(11):945-953. doi: 10.1177/1060028017719716. Epub 2017 Jul 5.

PMID:
28677404
26.

The societal cost of heroin use disorder in the United States.

Jiang R, Lee I, Lee TA, Pickard AS.

PLoS One. 2017 May 30;12(5):e0177323. doi: 10.1371/journal.pone.0177323. eCollection 2017.

27.

Choice Blindness and Health-State Choices among Adolescents and Adults.

Law EH, Pickard AL, Kaczynski A, Pickard AS.

Med Decis Making. 2017 Aug;37(6):680-687. doi: 10.1177/0272989X17700847. Epub 2017 Apr 5.

PMID:
28380316
28.

Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS, Rowen D, Street DJ, Velikova G, Young TA, King MT.

Qual Life Res. 2017 Aug;26(8):2247-2248. doi: 10.1007/s11136-017-1546-0. No abstract available.

PMID:
28337638
29.

Comparative Effectiveness of Long-Acting Beta2 -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease.

Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA.

Pharmacotherapy. 2017 Apr;37(4):447-455. doi: 10.1002/phar.1913.

PMID:
28226405
30.

Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment.

Pickard AS, Huynh L, Ivanova JI, Totev T, Graham S, Mühlbacher AC, Roy A, Duh MS.

J Patient Rep Outcomes. 2017;2(1):13. doi: 10.1186/s41687-018-0032-y. Epub 2018 Mar 1.

31.

Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment.

Norman R, Kemmler G, Viney R, Pickard AS, Gamper E, Holzner B, Nerich V, King M.

Value Health. 2016 Dec;19(8):1033-1038. doi: 10.1016/j.jval.2016.07.003. Epub 2016 Sep 21.

32.

Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale.

Krabbe PFM, Stolk EA, Devlin NJ, Xie F, Quik EH, Pickard AS.

Eur J Health Econ. 2017 Nov;18(8):967-977. doi: 10.1007/s10198-016-0841-y. Epub 2016 Nov 2.

33.

Engaging Patients and Caregivers to Design Transitional Care Management Services at a Minority Serving Institution.

Ursan ID, Krishnan JA, Pickard AS, Calhoun E, DiDomenico R, Prieto-Centurion V, Sullivan JB, Valentino L, Williams MV, Joo M.

J Health Care Poor Underserved. 2016;27(1):352-365.

PMID:
27763474
34.

Transforming Latent Utilities to Health Utilities: East Does Not Meet West.

Xie F, Pullenayegum E, Pickard AS, Ramos Goñi JM, Jo MW, Igarashi A.

Health Econ. 2017 Dec;26(12):1524-1533. doi: 10.1002/hec.3444. Epub 2016 Oct 16.

PMID:
27747973
35.

EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.

Pickard AS, Gooderham M, Hartz S, Nicolay C.

J Med Econ. 2017 Jan;20(1):19-27. Epub 2016 Aug 15.

PMID:
27471948
36.

Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.

Melzer AC, Feemster LC, Crothers K, Carson SS, Gillespie SE, Henderson AG, Krishnan JA, Lindenauer PK, McBurnie MA, Mularski RA, Naureckas ET, Pickard AS, Au DH; COPD Outcomes-based Network for Clinical Effectiveness and Research Translation Consortium.

Ann Am Thorac Soc. 2016 Sep;13(9):1490-6. doi: 10.1513/AnnalsATS.201601-075OC.

37.

Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DS, Fayers PM, Kemmler G, Peacock S, Pickard AS, Rowen D, Street DJ, Velikova G, Young TA, King MT.

Qual Life Res. 2016 Sep;25(9):2401. No abstract available.

PMID:
27060090
38.

Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.

Qual Life Res. 2016 Oct;25(10):2683. doi: 10.1007/s11136-016-1260-3. No abstract available.

PMID:
27060088
39.

Using Patient-reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of Cancer.

Pickard AS, Jiang R, Lin HW, Rosenbloom S, Cella D.

Clin Ther. 2016 Apr;38(4):769-77. doi: 10.1016/j.clinthera.2016.03.009. Epub 2016 Apr 1.

PMID:
27041407
40.

QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

King MT, Costa DS, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.

Qual Life Res. 2016 Mar;25(3):625-36. doi: 10.1007/s11136-015-1217-y. Epub 2016 Jan 20. Erratum in: Qual Life Res. 2016 Oct;25(10 ):2683.

41.

Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease.

Saraf SL, Oh AL, Patel PR, Jalundhwala Y, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Hassan J, Peace D, Quigley JG, Khan I, Molokie RE, Hsu LL, Mahmud N, Levinson DJ, Pickard AS, Garcia JG, Gordeuk VR, Rondelli D.

Biol Blood Marrow Transplant. 2016 Mar;22(3):441-8. doi: 10.1016/j.bbmt.2015.08.036. Epub 2015 Sep 5.

42.

Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DS, Fayers PM, Kemmler G, Peacock S, Pickard AS, Rowen D, Street DJ, Velikova G, Young TA, King MT.

Qual Life Res. 2016 Mar;25(3):637-49. doi: 10.1007/s11136-015-1115-3. Epub 2015 Sep 5. Erratum in: Qual Life Res. 2016 Sep;25(9):2401. Qual Life Res. 2017 Mar 23;:.

PMID:
26342928
43.

Using linked electronic data to validate algorithms for health outcomes in administrative databases.

Lee WJ, Lee TA, Pickard AS, Shoaibi A, Schumock GT.

J Comp Eff Res. 2015 Aug;4(4):359-66. doi: 10.2217/cer.15.14.

PMID:
26274797
44.

A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE).

Xie F, Pickard AS, Krabbe PF, Revicki D, Viney R, Devlin N, Feeny D.

Pharmacoeconomics. 2015 Aug;33(8):867-77. doi: 10.1007/s40273-015-0292-9.

45.
46.

Is it time to update societal value sets for preference-based measures of health?

Pickard AS.

Pharmacoeconomics. 2015 Mar;33(3):191-2. doi: 10.1007/s40273-015-0253-3. No abstract available.

PMID:
25586758
47.

Do health preferences contradict ordering of EQ-5D labels?

Craig BM, Pickard AS, Rand-Hendriksen K.

Qual Life Res. 2015 Jul;24(7):1759-65. doi: 10.1007/s11136-014-0897-z. Epub 2014 Dec 18.

48.

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.

Golicki D, Niewada M, Karlińska A, Buczek J, Kobayashi A, Janssen MF, Pickard AS.

Qual Life Res. 2015 Jun;24(6):1555-63. doi: 10.1007/s11136-014-0873-7. Epub 2014 Nov 26.

49.

Inhaled Anticholinergics and Risk for Acute Urinary Retention: A Case-Crossover and Case-Time-Control Study.

Lin FJ, Joo MJ, Pickard AS, Dilokthornsakul P, Lee TA.

Value Health. 2014 Nov;17(7):A776. doi: 10.1016/j.jval.2014.08.350. Epub 2014 Oct 26. No abstract available.

50.

Validity of the Eq-5d-5l in Stroke Patients.

Golicki D, Niewada M, Buczek J, Karlinska A, Kobayashi A, Janssen MF, Pickard AS.

Value Health. 2014 Nov;17(7):A570. doi: 10.1016/j.jval.2014.08.1906. Epub 2014 Oct 26. No abstract available.

Supplemental Content

Loading ...
Support Center